Creative Biolabs

Creative Biolabs has extensive experience in coronavirus research. Provide comprehensive and high-quality SARS-CoV-2 vaccine research and development related services and products.
This video briefly introduces the SARS-CoV-2 vaccine type and pipeline. If you need more information about SARS-CoV-2, please visit https://sars-cov-2.creative-biolabs.com/drug-discovery-services-for-sars-cov2.htm.

SARS-CoV-2 Vaccine Introduction

Creative Biolabs has extensive experience in exosome-related services and provides comprehensive high-quality exosome-related products.
This video introduces the exosome biogenesis and therapeutics knowledge. If you want more exosome related knowledge，products and services, please visit https://www.creative-biolabs.com/exosome/therapeutic-application-of-exosome.htm.

Exosomes Biogenesis & Therapeutics

Genome editing is a set of methods used to change the DNA of a cell with single base-pair precision. It is a specific form of gene therapy, and the engineering of cells through genome editing has the potential to create a new class of medicines for the treatment of both genetic and nongenetic diseases. Today we will discuss the basic theories and clinic stages of genome editing methods, and Creative Biolabs' gene editing solutions for gene therapy development.
https://www.creative-biolabs.com/gene-therapy/gene-editing-for-gene-therapy.htm

Genome Editing Introduction

T-cell redirecting therapies with gene-engineered CAR T-cells and T-cell engaging bispecific antibodies (bsAb) are showing promising results in clinical trials. To guide precision immunotherapy, other factors should also be taken into consideration, including greater availability of immune targets and compounds with different modes of action during the development of new biomarkers, and determinants of response and resistance to a specific regimen.
https://www.creative-biolabs.com/bsab/new-ways-of-evaluating-the-tumor-immune-microenvironment-from-bench-to-bedside.htm

Immunotherapies and Tumor Immune Microenvironment

The severity and emergency of SARS-CoV-2 infection spurs an urgent need for antiviral drug and vaccine discovery. Creative Biolabs has spent considerable efforts to provide scientific support and comprehensive services to promote the success of this combat. 
https://sars-cov-2.creative-biolabs.com/novel-coronavirus-sars-cov2.htm

SARS-CoV-2 Introduction-Creative Biolabs

Creative Biolabs invited Dr. Bruno Paiva to give us a clearer understanding of novel immunotherapies and the combined methods to be applied in the research of tumorigenesis and drug development.

Key webinar highlights:
Recognizing the "friend or foe" relationship between (blood) cancer and immunityLeveraging on the immunotherapies for malignant and nonmalignant (hematological) tumorsNeed for next-generation immune monitoring
https://www.creative-biolabs.com/bsab/new-ways-of-evaluating-the-tumor-immune-microenvironment-from-bench-to-bedside.htm

Creative Biolabs

Home

Videos

Playlists

About

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.